Muhannad R M Salih
Overview
Explore the profile of Muhannad R M Salih including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
56
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
R M Salih M, Y Abd A, Fawzi H
F1000Res
. 2022 Oct;
11:367.
PMID: 35811798
Asthma is a major global health issue characterized by chronic airway inflammation. It is linked to a high disease burden and disproportionately high healthcare utilization in severe, uncontrolled cases compared...
2.
R M Salih M, Y Abd A
J Pharm Bioallied Sci
. 2022 Jan;
13(3):291-297.
PMID: 35017884
Background: Self-medication (SM) is the self-administration of treatment without a medical prescription or consultation or guidance from a physician or a health-care provides. Aim And Objectives: This study aims at...
3.
Al-Lela O, Bahari M, R M Salih M, Al-Abbassi M, Elkalmi R, Jamshed S
BMC Pediatr
. 2014 Feb;
14:29.
PMID: 24485194
Background: Since last 100 years, immunization rate is one of the best public health outcome and service indicators. However, the immunization system is still imperfect; there are many countries that...
4.
Al-Lela O, Bahari M, Al-Qazaz H, R M Salih M, Jamshed S, Elkalmi R
BMC Pediatr
. 2014 Jan;
14:20.
PMID: 24460878
Background: Immunization rate is one of the best public health outcome and service indicators of the last 100 years. Parental decisions regarding immunization are very important to improve immunization rate....
5.
R M Salih M, Bahari M, Shafie A, Hassali M, Al-Lela O, Y Abd A, et al.
Epilepsy Res
. 2012 Oct;
104(1-2):151-7.
PMID: 23103061
Treatment with antiepileptic drugs is commonly guided by serum level monitoring. Such monitoring requires expensive laboratory equipment and products. However, well-conducted studies on the cost-effectiveness of therapeutic drug monitoring for...
6.
R M Salih M, Bahari M, Shafie A, Hassali M, Al-Lela O, Y Abd A, et al.
Seizure
. 2012 Sep;
21(10):764-9.
PMID: 22939458
Purpose: Aims of this study were to estimate the first-year medical care costs of newly diagnosed children with structural-metabolic epilepsy and to determine the cost-driving factors in the selected population....
7.
R M Salih M, Bahari M, Hassali M, Shafie A, Al-Lela O, Y Abd A, et al.
J Pharm Pract
. 2012 Jul;
26(3):192-7.
PMID: 22797836
Objectives: To assess the practices associated with the application of therapeutic drug monitoring (TDM) for antiepileptic drugs (AEDs) in the management of children with structural-metabolic epilepsy. Methods: It was a...
8.
Al-lela O, Bahari M, Al-Abbassi M, R M Salih M, Basher A
J Trop Pediatr
. 2012 Apr;
58(6):441-5.
PMID: 22538210
To identify the immunization providers' characteristics associated with immunization rate in children younger than 2 years. A cohort and a cluster sampling design were implemented; 528 children between 18 and...
9.
Al-Lela O, Bahari M, Al-Abbassi M, R M Salih M, Basher A
Vaccine
. 2012 Apr;
30(26):3862-6.
PMID: 22521848
The immunization status of children is improved by interventions that increase community demand for compulsory and non-compulsory vaccines, one of the most important interventions related to immunization providers. The aim...
10.
R M Salih M, Bahari M, Y Abd A
Nutr J
. 2011 Jan;
9:71.
PMID: 21194458
Objectives: To conduct a systematic review for the evidence supporting or disproving the reality of parenteral nutrition- antiepileptic drugs interaction, especially with respect to the plasma protein-binding of the drug....